Trial Profile
A randomized double-blind multicenter study to evaluate the tolerability and effectiveness of etoricoxib 90 mg q.d. [once daily] vs. diclofenac sodium 50 mg t.i.d [three times daily] in patients with osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Acronyms EDGE
- Sponsors Organon
- 14 Nov 2006 Status change
- 28 Oct 2005 New trial record.